Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M91,185Revenue (TTM) $M11,678Net Margin (%)18.3Altman Z-Score4.2
Enterprise Value $M96,608EPS (TTM) $2.7Operating Margin %28.1Piotroski F-Score5
P/E(ttm)43.9Beneish M-Score-2.6Pre-tax Margin (%)21.2Higher ROA y-yN
Price/Book11.910-y EBITDA Growth Rate %--Quick Ratio4.2Cash flow > EarningsY
Price/Sales8.05-y EBITDA Growth Rate %16.1Current Ratio4.4Lower Leverage y-yY
Price/Free Cash Flow26.2y-y EBITDA Growth Rate %20.9ROA % (ttm)7.9Higher Current Ratio y-yN
Dividend Yield %--PEG2.7ROE % (ttm)35.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M781ROIC % (ttm)21.2Gross Margin Increase y-yY

Gurus Latest Trades with CELG

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

CELG is held by these investors:

CELG: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOUGHLIN JAMES JDirector 2017-05-01Sell9,250$124-5.82view
KAPLAN GILLADirector 2017-03-30Sell14,033$123.83-5.69view
VESSEY RUPERTSee remarks 2017-03-01Sell4,000$124.42-6.14view
CASEY MICHAEL DDirector 2017-02-27Sell7,500$121.55-3.92view
VESSEY RUPERTSee remarks 2016-11-22Sell2,500$123.18-5.2view
PEHL MICHAEL F.See remarks 2016-11-10Sell22,052$121.04-3.52view
Friedman Michael ADirector 2016-11-09Sell18,600$116.10.59view
HUGIN ROBERT Jsee remarks 2016-11-09Sell100,000$120-2.68view
Friedman Michael ADirector 2016-10-03Sell56,116$103.6612.66view
MARIO ERNESTDirector 2016-09-23Sell15,000$109.426.73view

Press Releases about CELG :

Quarterly/Annual Reports about CELG:

News about CELG:

Articles On GuruFocus.com
David Rolfe Gains 3 Holdings, Sells 2 Others in 1st Quarter May 16 2017 
Study These Gurus, but Don’t Buy Their Funds Apr 14 2017 
Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary Feb 14 2017 
Celgene Switzerland Invests in Jounce Therapeutics Feb 02 2017 
Eaton Vance Worldwide Health Sciences Fund 4th Quarter Commentary Jan 24 2017 
9 Stocks Ray Dalio Continues to Buy Dec 22 2016 
When Is the PEG Ratio Superior to the P/E Ratio? Part 2 Nov 03 2016 
Abbott Develops AML Tests With Celgene and Agios Oct 13 2016 
Celgene: Is It a Buy? Jun 21 2016 
5 Attractive Biotechnology Stocks for Healthy Long-term Returns Jun 10 2016 

More From Other Websites
Meet the Cancer Therapy that Could Become the Second Best-Selling Drug in the World by Year's... May 29 2017
3 Stocks the Market Is Wrong About May 28 2017
Better Buy: Celgene Corporation vs. Bristol-Myers Squibb May 28 2017
I Still Can't Believe Juno Therapeutics Spent $46.4 Million on This Failed Drug May 25 2017
Short Sellers Raise the Stakes in Major Biotechs May 25 2017
The Zacks Analyst Blog Highlights: Regeneron, Amgen and Celgene May 25 2017
Kyprolis Could Significantly Drive Amgen’s Revenue Growth in 2017 May 25 2017
3 Healthcare Stocks for Savvy Investors May 24 2017
Biotech Stock Roundup: FDA Nod for Regeneron RA Drug, Amgen Hit by Study Data May 24 2017
Blog Coverage: Celgene Reported Positive Late Stage Results from Trial of Ozanimod in Patients with... May 24 2017
Celgene (CELG) Multiple Sclerosis Drug Meets Primary Endpoint May 23 2017
Zymeworks: Early But Compelling Data, Large Biopharma Partners And A Potential June Catalyst May 23 2017
Will Novartis' MS Drug Stomp Celgene's Before It Even Hits The Market? May 22 2017
Celgene's multiple sclerosis drug succeeds in late-stage trial May 22 2017
Celgene Stock Rises Premarket on Positive Late-Stage Test Results for Multiple Sclerosis Treatment May 22 2017
Celgene reports positive results in trial of multiple sclerosis treatment May 22 2017
Celgene Announces Positive Results from RADIANCE, the Second Pivotal Phase III Trial of Oral... May 22 2017
5 Leadership Lessons From Exceptionally Successful CEOs May 21 2017
Why Long-Term Investors Should Prefer Celgene Over Biogen May 21 2017
Why Stay Bullish On Gilead May 19 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)